STAAR Surgical Provides COVID-19 Business Update

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided a business update relating to the evolving COVID-19 global health care concern. “We have made the decision to get out in front of our traditional earnings call communications to let you know how STAAR is faring during the COVID-19 pandemic. It is clear that the health and safety of everyone ar

Full Story →